Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
SILO.JK Stock Summary
In the News
SILO.JK Financial details
Company Rating
Strong Buy
Market Cap
29438.83B
Income
1106.19B
Revenue
10832.12B
Book val./share
583.29
Cash/share
79.14
Dividend
19.67
Dividend %
0.93%
Employees
13.96K
Optionable
No
Shortable
Yes
Earnings
25 Apr 2024
P/E
24.93
Forward P/E
20.67
PEG
3.84
P/S
2.54
P/B
3.65
P/C
30.33
P/FCF
45.57
Quick Ratio
0.38
Current Ratio
1.15
Debt / Equity
0.11
LT Debt / Equity
0.02
-
-
EPS (TTM)
85.92
EPS next Y
116.1
EPS next Q
-
EPS this Y
35.73%
EPS next Y
35.13%
EPS next 5Y
-
EPS last 5Y
124.52%
Revenue last 5Y
9.8%
Revenue Q/Q
12.78%
EPS Q/Q
40.41%
-
-
-
-
SMA20
-0.43%
SMA50
10.13%
SMA100
-1.43%
Inst Own
0%
Inst Trans
0%
ROA
10%
ROE
15%
ROC
0.2%
Gross Margin
39%
Oper. Margin
15%
Profit Margin
10%
Payout
-
Shs Outstand
12.96B
Shs Float
1.14B
-
-
-
-
Target Price
-
52W Range
1350.0-2740.0
52W High
-12.41%
52W Low
+77.78%
RSI
61
Rel Volume
0.46
Avg Volume
3.25M
Volume
1.48M
Perf Week
6.67%
Perf Month
8.6%
Perf Quarter
12.68%
Perf Half Y
20%
-
-
-
-
Beta
0.117
-
-
Volatility
49.86%, 52.98%
Prev Close
0%
Price
2400
Change
0.84%
SILO.JK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 458.6 | 539.59 | 547.21 | 725.37 | 966.73 | |
Net income per share | 1.24 | -25.6 | 8.94 | 52.12 | 70.74 | |
Operating cash flow per share | 15.66 | 50.09 | 102.87 | 157.19 | 151.84 | |
Free cash flow per share | -47.34 | 10.59 | 74.86 | 108.9 | 31.67 | |
Cash per share | 17 | 24.32 | 71.38 | 148.93 | 115.75 | |
Book value per share | 483.35 | 456.81 | 458.9 | 498.08 | 706.46 | |
Tangible book value per share | 447.51 | 423.86 | 424.27 | 464.24 | 663.77 | |
Share holders equity per share | 483.35 | 456.81 | 458.9 | 498.08 | 706.46 | |
Interest debt per share | 21.05 | 23.04 | 52.02 | 46.59 | 55.95 | |
Market cap | 5836.5B | 11299.07B | 8933.02B | 13863.57B | 12405.45B | |
Enterprise value | 5872.66B | 11257.14B | 8630.28B | 12513.68B | 11851.93B | |
P/E ratio | 360.68 | -33.93 | 76.9 | 20.57 | 17.81 | |
Price to sales ratio | 0.98 | 1.61 | 1.26 | 1.48 | 1.3 | |
POCF ratio | 28.66 | 17.34 | 6.68 | 6.82 | 8.3 | |
PFCF ratio | -9.48 | 82.06 | 9.18 | 9.84 | 39.79 | |
P/B Ratio | 0.93 | 1.9 | 1.5 | 2.15 | 1.78 | |
PTB ratio | 0.93 | 1.9 | 1.5 | 2.15 | 1.78 | |
EV to sales | 0.98 | 1.6 | 1.21 | 1.33 | 1.25 | |
Enterprise value over EBITDA | 14.82 | 36.13 | 9.69 | 6.72 | 6.38 | |
EV to operating cash flow | 28.84 | 17.28 | 6.46 | 6.15 | 7.93 | |
EV to free cash flow | -9.54 | 81.75 | 8.87 | 8.88 | 38.02 | |
Earnings yield | 0 | -0.03 | 0.01 | 0.05 | 0.06 | |
Free cash flow yield | -0.11 | 0.01 | 0.11 | 0.1 | 0.03 | |
Debt to equity | 0.04 | 0.05 | 0.1 | 0.09 | 0.07 | |
Debt to assets | 0.03 | 0.04 | 0.07 | 0.06 | 0.05 | |
Net debt to EBITDA | 0.09 | -0.13 | -0.34 | -0.73 | -0.3 | |
Current ratio | 1.8 | 1.35 | 1.44 | 1.59 | 1.23 | |
Interest coverage | 8.81 | 1.4 | 5.49 | 26.87 | 26.67 | |
Income quality | 12.58 | -1.92 | 11.51 | 3.02 | 2.15 | |
Dividend Yield | 0 | 0 | 0 | 0.02 | 0.02 | |
Payout ratio | 0 | 0 | 0 | 0.33 | 0.36 | |
Sales general and administrative to revenue | 0.09 | 0.09 | 0.06 | 0.07 | 0.07 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.06 | 0.06 | 0.06 | 0.06 | 0.05 | |
Capex to operating cash flow | -4.02 | -0.79 | -0.27 | -0.31 | -0.79 | |
Capex to revenue | -0.14 | -0.07 | -0.05 | -0.07 | -0.12 | |
Capex to depreciation | 0 | -0.94 | -0.45 | -0.66 | -1.48 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 116.32 | 512.98 | 303.83 | 764.27 | 1.06K | |
ROIC | 0 | 0.01 | 0.02 | 0.1 | 0.1 | |
Return on tangible assets | 0 | -0.05 | 0.01 | 0.08 | 0.08 | |
Graham Net | -11.97 | -34.48 | -32.83 | 15.52 | -45.07 | |
Working capital | 786.51B | 474.84B | 740.22B | 1312.37B | 508.87B | |
Tangible asset value | 5820.37B | 5512.8B | 5512.73B | 6004.42B | 6535.21B | |
Net current asset value | 388.18B | 91.08B | 12.28B | 764.84B | 72.47B | |
Invested capital | 0.04 | 0.05 | 0.1 | 0.09 | 0.07 | |
Average receivables | 604.54B | 1193.33B | 1205.48B | 1219.26B | 1222.44B | |
Average payables | 354.38B | 334.29B | 331.48B | 399.64B | 455.56B | |
Average inventory | 193.4B | 200.79B | 236.57B | 281.5B | 251.98B | |
Days sales outstanding | 73.99 | 61.25 | 63.31 | 46.89 | 47.54 | |
Days payables outstanding | 30.36 | 25.22 | 25.21 | 29.71 | 26.95 | |
Days of inventory on hand | 17.13 | 16.08 | 19.93 | 19.13 | 12.31 | |
Receivables turnover | 4.93 | 5.96 | 5.76 | 7.78 | 7.68 | |
Payables turnover | 12.02 | 14.47 | 14.48 | 12.29 | 13.54 | |
Inventory turnover | 21.31 | 22.7 | 18.32 | 19.08 | 29.64 | |
ROE | 0 | -0.06 | 0.02 | 0.1 | 0.1 | |
Capex per share | -62.99 | -39.51 | -28.01 | -48.29 | -120.18 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 194.34 | 199.58 | 204.63 | 202.4 | 228.52 | |
Net income per share | 18.41 | 19.08 | 19.24 | 19.55 | 27.42 | |
Operating cash flow per share | 33.78 | 34.15 | 19.24 | 14.06 | 55.83 | |
Free cash flow per share | -8.36 | 33.78 | 5.52 | -34.08 | 41.36 | |
Cash per share | 97.82 | 87.93 | 95.76 | 67.37 | 79.14 | |
Book value per share | 516.45 | 536.7 | 556.53 | 556.34 | 583.29 | |
Tangible book value per share | 484.63 | 504.27 | 525.42 | 525.98 | 554.51 | |
Share holders equity per share | 516.45 | 536.7 | 556.53 | 556.34 | 583.29 | |
Interest debt per share | 39.53 | 40.78 | 62.34 | 88.16 | 67.94 | |
Market cap | 13364.41B | 16329.29B | 19651.27B | 24343.01B | 26456.09B | |
Enterprise value | 12664.36B | 15775.78B | 19307.87B | 24699.37B | 26306.81B | |
P/E ratio | 13.98 | 16.51 | 19.68 | 23.98 | 18.6 | |
Price to sales ratio | 5.3 | 6.31 | 7.4 | 9.26 | 8.93 | |
POCF ratio | 30.49 | 36.9 | 78.73 | 133.34 | 36.54 | |
PFCF ratio | -123.25 | 37.3 | 274.54 | -55.02 | 49.32 | |
P/B Ratio | 1.99 | 2.35 | 2.72 | 3.37 | 3.5 | |
PTB ratio | 1.99 | 2.35 | 2.72 | 3.37 | 3.5 | |
EV to sales | 5.02 | 6.1 | 7.27 | 9.4 | 8.88 | |
Enterprise value over EBITDA | 23.59 | 28.68 | 34.04 | 43.07 | 37.35 | |
EV to operating cash flow | 28.89 | 35.64 | 77.35 | 135.29 | 36.33 | |
EV to free cash flow | -116.79 | 36.04 | 269.74 | -55.83 | 49.04 | |
Earnings yield | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | -0.01 | 0.03 | 0 | -0.02 | 0.02 | |
Debt to equity | 0.08 | 0.07 | 0.11 | 0.16 | 0.11 | |
Debt to assets | 0.05 | 0.05 | 0.08 | 0.11 | 0.08 | |
Net debt to EBITDA | -1.3 | -1.01 | -0.61 | 0.62 | -0.21 | |
Current ratio | 1.38 | 1.23 | 1.35 | 1.02 | 1.15 | |
Interest coverage | 56.59 | 22.35 | 34.45 | 26.16 | 37.29 | |
Income quality | 1.83 | 1.79 | 1 | 0.72 | 2.04 | |
Dividend Yield | 0 | 0 | 0 | 0.01 | 0 | |
Payout ratio | 0 | 0.02 | 0 | 1.01 | 0.04 | |
Sales general and administrative to revenue | 0.06 | 0.06 | 0.06 | 0.07 | 0.06 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |
Capex to operating cash flow | -1.25 | -0.01 | -0.71 | -3.42 | -0.26 | |
Capex to revenue | -0.22 | 0 | -0.07 | -0.24 | -0.06 | |
Capex to depreciation | -2.74 | -0.02 | -0.76 | -2.65 | -0.8 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 462.56 | 480.01 | 490.89 | 494.63 | 599.83 | |
ROIC | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | |
Return on tangible assets | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
Graham Net | -20.06 | -34.24 | -39.34 | -73.8 | -53.04 | |
Working capital | 782.84B | 508.87B | 756.2B | 54.02B | 414.78B | |
Tangible asset value | 6288.19B | 6535.21B | 6815.29B | 6828.72B | 7191.3B | |
Net current asset value | 292.16B | 72.47B | 16.06B | -348.58B | 27.35B | |
Invested capital | 0.08 | 0.07 | 0.11 | 0.16 | 0.11 | |
Average receivables | 1218.91B | 1246.05B | 1315.4B | 1503.98B | 1646.1B | |
Average payables | 442.99B | 436.8B | 453.26B | 450.08B | 487.75B | |
Average inventory | 221.56B | 200.63B | 192.66B | 181.63B | 182.77B | |
Days sales outstanding | 44.7 | 43.14 | 47.17 | 55.38 | 50.88 | |
Days payables outstanding | 25.35 | 25.77 | 25.5 | 24.04 | 27.85 | |
Days of inventory on hand | 11.71 | 11.77 | 10.07 | 9.93 | 9.58 | |
Receivables turnover | 2.01 | 2.09 | 1.91 | 1.63 | 1.77 | |
Payables turnover | 3.55 | 3.49 | 3.53 | 3.74 | 3.23 | |
Inventory turnover | 7.69 | 7.65 | 8.94 | 9.07 | 9.4 | |
ROE | 0.04 | 0.04 | 0.03 | 0.04 | 0.05 | |
Capex per share | -42.14 | -0.37 | -13.73 | -48.14 | -14.46 |
SILO.JK Frequently Asked Questions
What is PT Siloam International Hospitals Tbk stock symbol ?
PT Siloam International Hospitals Tbk is a ID stock and trading under the symbol SILO.JK
What is PT Siloam International Hospitals Tbk stock quote today ?
PT Siloam International Hospitals Tbk stock price is $2400 today.
Is PT Siloam International Hospitals Tbk stock public?
Yes, PT Siloam International Hospitals Tbk is a publicly traded company.